We help chemical and pharmaceutical executives who are searching for new products and therapies to drive future profitable growth.

M&A and licensing deals allow them to diversify product portfolios and to secure the company's drug development pipeline. Our core competence is the target‐oriented application of combined transaction and industry know‐how regarding traditional chemical based or biotechnological drugs and therapeutic areas including the respective legal frameworks.

At the same time, we are in a position to offer access to decision makers throughout the entire Chemicals & Life Sciences industry. FALK & Co Corporate Finance's Chemicals & Life Sciences team specializes in conducting divestitures and acquisitions within the Chemicals & Life Sciences industry.